top of page


Unlocking the Nanoscale​

Our imaging quantifies how a treatment affects cells and biomarkers in intact tissue, providing translational insights that support decision-making from preclinical to clinical stages.

22_HumanParaffin_Tnk005_Channels_stated_in_image_names_Large_stack_MIP(1-21).jpg

What We Do

We help researchers understand how their drug candidates interact with biological tissue. Using advanced, high-resolution microscopy and image analysis with advanced segmentation, we visualise treatment effects such as changes in cell structure, biomarker distribution, and tissue organization. These insights make it easier to evaluate efficacy and guide the next step in development.

    Testimonials   

image.png

"Q32 Bio has collaborated with Magnephy on several preclinical studies, and the experience has been outstanding.  Magnephy brought a wealth of expertise to the table, carefully listening to the scientific questions we were trying to ask and suggesting potential solutions. During study execution the work was excellent, the communication prompt and clear, with regular check-ins to make sure they fully understood our needs and offers to modify the approach as the data emerged. 

  

In the end, the results far exceeded even our most optimistic expectations... "

Publications

Deep learning–based segmentation and quantification of podocyte foot process morphology suggests differential patterns of foot process effacement across kidney pathologies

David Unnersjö-Jess, et al., – 2023

Skjermbilde 2025-10-04 kl. 15.19.02.png

Get in Touch

Address

Fakultetsgränd 8,
114 19 Stockholm,
Sweden

Contact

contact@magnephy.com

​

If you're a pharmaceutical developer or an investor, feel free to use our Booking tool by clicking here.

Linkedin

  • LinkedIn
  • LinkedIn

SUPPORTED BY

image.png
image.png
image.png
image.png
image.png
image.png
image.png

Fakultetsgränd 8, 114 19 Stockholm, Sweden

  • LinkedIn

© 2025 by Magnephy AB. 

bottom of page